General Information of the Compound
Compound ID
CP0541031
Compound Name
5-chloro-4-(4-hydroxyphenoxy)-2-(4-propan-2-ylphenyl)pyridazin-3-one
    Show/Hide
Structure
Formula
C19H17ClN2O3
Molecular Weight
356.809
Canonical SMILES
CC(C)c1ccc(cc1)-n1ncc(Cl)c(Oc2ccc(O)cc2)c1=O
    Show/Hide
InChI
InChI=1S/C19H17ClN2O3/c1-12(2)13-3-5-14(6-4-13)22-19(24)18(17(20)11-21-22)25-16-9-7-15(23)8-10-16/h3-12,23H,1-2H3
    Show/Hide
InChIKey
STLIXHHVADZBSX-UHFFFAOYSA-N
Physicochemical Property
logP
4.5072
Rotatable Bonds
4
Heavy Atom Count
25
Polar Areas
64.35
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 50904492
SID: 163478837
ChEMBL ID
CHEMBL2207119
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06160, Neuropeptides B/W receptor type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 4800 nM
   TI
   LI
   LO
   TS